Shoulder dystocia is an emergency birth complication in which the baby’s head has been born but one of the shoulders becomes stuck behind the mother’s pubic bone, delaying the birth of the baby’s body. The dystocia must be dealt with within 7 minutes in order to prevent serious injury or death to the baby. A series of manual maneuvers is currently used to release the baby’s shoulders.
There are an estimated 1.5 million cases of shoulder dystocia annually worldwide. Shoulder dystocia can result in maternal injury, neonatal injury, permanent disability and death and is the most common cause of obstetric brachial plexus injury (OBPI). Approximately 50,000 newborns each year worldwide are left with permanent brachial plexus injury due to shoulder dystocia.
The Yaari Extractor™ is a simple mechanical solution to aid physician in resolving shoulder dystocia births. The extractor is comprised of two control arms and a flexible engagement element. The flexible element is introduced into the birth canal and is wrapped around the fetal shoulder from behind the maternal pubic bone. Using the control arms, the physician manipulates the fetal shoulder to a position where the maternal pushing effort can deliver the shoulder.
The Yaari Extractor resolves shoulder dystocia by removing the anterior fetal shoulder from behind the maternal pubic bone and moving it to the oblique diameter where it is delivered safely.
This is achieved with three simple steps and without applying traction to the fetal head or neck:
CAUTION: Investigational device. Limited by United States law to investigational use.
Single-use mechanical tool.
Combines both rigid and flexible elements to best suit anatomy with no traction applied to the fetal head or brachial plexus.
Direct and controlled application of limited force.
The maternal pelvis is not used as a fulcrum.
FetalEase is a privately held Israeli start-up company dedicated to commercializing the Yaari Extractor. The device was invented by Dr. Abraham Yaari, an OB/GYN with over 20 years of experience delivering babies in the US and Israel.
We are driven by our mission to prevent unnecessary injuries to mother and newborn and seek to collaborate and partner with organizations dedicated to improving outcomes of complicated births globally
More than 20 years’ experience in the R&D and commercialization of medical devices. Former CEO of Rafael Medical Technologies, CardioFlow and currently co-Founder of Ark Surgical and Restore Medical.
Trained as an OB/GYN in the US and in Israel, followed by over 20 years of practice in those countries. Co-founder of Ark Surgical.
Entrepreneur and impact investor with a business background in real-estate and private equity deals, as well as with NGOs.
Senior healthcare industry leader and OB/GYN physician. Former Chief Medical Officer of Laborie and of Clinical Innovations. Currently CMO of Biote.
Former President and CEO of Alydia Health from 2016 to 2020. Alydia Health was acquired by Organon in June 2021 for $240M. Previously, she also served as Marketing Manager at General Surgical Innovations, subsequently acquired by Tyco.
MFM specialist in Chambersburg, PA. Practices at WellSpanMaternal-Fetal Medicine and is affiliated with MedStar Franklin Square Medical Center. Researched and published extensively on the topic of shoulder dystocia and is considered a leading expert on the subject.
Executive level Regulatory Affairs and Clinical Research professional with over 30 years of experience and expertise. Former Senior Vice President/Vice President of Regulatory Affairs and Clinical Research for Conceptus and Kyphon. Managed the FDA clearance process for Alydia Health’s Jada device.
Past Medical Director and Vice President, Global Medical Affairs at Hologic and Chief Medical Officer of Alydia Health. Dr. Evantash previously served as Division Chief of Obstetrics and Gynecology at Tufts Medical Center. He received his medical degree from the University of Pennsylvania School of Medicine as a Penn Scholar.